Literature DB >> 26111498

HBsAg spontaneous seroclearance in a cohort of HBeAg-seronegative patients with chronic hepatitis B virus infection.

Zhen-Ge Han1, Zhong-Hong Qie2, Wei-Zhen Qiao3.   

Abstract

Loss of hepatitis B surface antigen (HBsAg) is considered to reflect the resolution of a hepatitis B virus (HBV) infection. Patient characteristics and various seromarkers were evaluated to characterize factors predicting spontaneous HBsAg loss in a cohort of HBeAg-seronegative patients with presumed chronic HBV infection. Relationships between seromarkers and HBsAg loss were assessed annually and after 6 years using binary logistic regression. Among the 634 participants, 117 (18.45%) cleared HBsAg after 6 years, with a 3.08% annual seroclearance rate. Baseline HBsAg levels and platelet (PLT) counts were predictors of HBsAg seroclearance. The HBsAg level predicted HBsAg seroclearance better than the PLT count (area under the receiver operating characteristic curve (AUROC): HBsAg, 0.965 (95%CI, 0.947-0.980) versus PLT count, 0.617 (95%CI, 0.561-0.669); P < 0.001). A cutoff HBsAg level of 10 IU/ml at baseline predicted spontaneous HBsAg seroclearance at 6 years with a diagnostic accuracy of 93.4%, a sensitivity of 87.2%, a specificity of 94.8%, a positive predictive value of 79.1%, and a negative predictive value of 97.0%. HBsAg seroclearance may occur more commonly than expected. A serum HBsAg level <10 IU/ml and PLT count were accurate predictors of clearance.
© 2015 The Authors. Journal of Medical Virology Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarkers; chronic disease; natural history; spontaneous remission; viral hepatitis

Mesh:

Substances:

Year:  2016        PMID: 26111498     DOI: 10.1002/jmv.24311

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.

Authors:  Kali Zhou; Caitlin Contag; Evans Whitaker; Norah Terrault
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-01-22

2.  A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.

Authors:  Safiehkhatoon Moshkani; Carolina Chiale; Sabine M Lang; John K Rose; Michael D Robek
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

3.  Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance.

Authors:  Hideaki Taniguchi; Yoshiaki Iwasaki; Masahito Aimi; Gaku Shimazaki; Akio Moriya
Journal:  JGH Open       Date:  2020-03-12

4.  HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously.

Authors:  Q Y Chen; X Y Wang; T J Harrison; X He; L P Hu; K W Li; H H Jia; Q L Yang; C Wang; Z L Fang
Journal:  Epidemiol Infect       Date:  2016-12-05       Impact factor: 4.434

Review 5.  Viral Biomarkers in Chronic HBeAg Negative HBV Infection.

Authors:  Emilia Hadziyannis; Andreas Laras
Journal:  Genes (Basel)       Date:  2018-09-27       Impact factor: 4.096

6.  A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort.

Authors:  Yi-Hao Yen; Kwong-Ming Kee; Fang-Ying Kuo; Kuo-Chin Chang; Tsung-Hui Hu; Sheng-Nan Lu; Jing-Houng Wang; Chao-Hung Hung; Chien-Hung Chen
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.

Authors:  Young Min Park; Seong Gyu Lee
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

8.  Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma.

Authors:  Sara Naimimohasses; Omar El Sherif; Mohammad Ashfaq; Niamh Nolan; Masood Iqbal; Susan McKiernan; Suzanne Norris
Journal:  Case Rep Gastroenterol       Date:  2017-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.